Your browser doesn't support javascript.
loading
Current Status and Perspectives of Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Hematological Malignancies.
Xie, Bailu; Li, Zhengdong; Zhou, Jianfeng; Wang, Wen.
Affiliation
  • Xie B; IASO Biotherapeutics Co., Ltd., No.77-78, Lane 887, Zuchongzhi Rd, Pudong, Shanghai 200120, China.
  • Li Z; Department of Breast Surgery, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200020, China.
  • Zhou J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Wang W; IASO Biotherapeutics Co., Ltd., No.77-78, Lane 887, Zuchongzhi Rd, Pudong, Shanghai 200120, China.
Cancers (Basel) ; 14(13)2022 Jun 30.
Article in En | MEDLINE | ID: mdl-35805001
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: China Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: China Country of publication: Suiza